Lansforsakringar Fondforvaltning’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$193M Sell
791,412
-31,098
-4% -$7.24M 1.01% 15
2025
Q4
$170M Buy
822,510
+13,899
+2% +$2.75M 0.84% 14
2025
Q3
$150M Buy
808,611
+18,417
+2% +$3.16M 0.78% 16
2025
Q2
$121M Sell
790,194
-54,743
-6% -$8.41M 0.69% 18
2025
Q1
$140M Sell
844,937
-7,013
-0.8% -$1.1M 0.86% 17
2024
Q4
$123M Buy
+851,950
New +$132M 0.69% 21

Other funds holding JNJ

Lansforsakringar Fondforvaltning's JNJ Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q1 2026, selling an estimated $7.24M and leaving 791,412 shares worth $193M. The position accounts for 1.01% of the portfolio, ranked #15.

Lansforsakringar Fondforvaltning first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 791,412 shares of Johnson & Johnson worth $193M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 31,098 Johnson & Johnson shares in Q1 2026, an estimated $7.24M.
  • Johnson & Johnson made up 1.01% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #15 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.